Matthew emphasizes the importance of understanding both the positive and negative aspects of psychedelics, likening it to the duality of the force. He highlights a decade-old paper that has become a foundational guide for conducting research in this field. Recent findings suggest that if psilocybin is approved as a medicine, it should be classified differently based on its risk profile.
